摘要:
The invention involves the identification of peptides which complex with HLA-Cw*16 molecules, and which may then provoke lysis of the cells to which they bind, by cytolytic T cells. Diagnostic and therapeutic uses are described.
摘要:
The invention involves the identification of an isolated nucleic acid molecule which encodes a tumor rejection antigen. Various uses of this nucleic acid molecule and the protein it encodes are discussed.
摘要:
In the field of cancer diagnostics and therapy, the invention relates to the identification of abnormal cells which express complexes of HLA-C-Clone 10 MHC antigen and a peptide derived from MAGE-1, and cytolytic T cells which recognize and lyse the abnormal cells. Cloned cytolytic T cells which recognize the HLA-C-Clone 10/MAGE-1 complex may be used to identify individuals having cancer cells which express the complex. Also disclosed are methods for isolating the genes encoding HLA-C-Clone 10 and MAGE-1.
摘要:
The invention relates to methods and compositions which modulate T lymphocyte activity. It has been found that two, T lymphocyte receptors, especially TCR and CD8, are present at a distance from each other on T lymphocyte surfaces. Via use of modulators which change the distance between these receptors, the activity of the T lymphocyte is modulated.
摘要:
The invention describes HLA class II binding peptides encoded by the MAGE-A3 tumor associated gene, as well as nucleic acids encoding such peptides and antibodies relating thereto. The peptides stimulate the activity and proliferation of CD4 T lymphocytes. Methods and products also are provided for diagnosing and treating conditions characterized by expression of the MAGE-A3 gene.